Bristol-Myers Squibb Co (NYSE:BMY)
$ 44.94 0.2 (0.45%) Market Cap: 91.10 Bil Enterprise Value: 138.84 Bil PE Ratio: 0 PB Ratio: 5.52 GF Score: 82/100

Bristol-Myers Squibb Co Investor Event to Discuss Data Presented at ASCO Transcript

Jun 08, 2021 / 05:00PM GMT
Release Date Price: $63.7 (-1.65%)
Timothy Power
Bristol-Myers Squibb Company - VP & Head of IR

Good afternoon. This is Tim Power from IR at Bristol-Myers. Welcome to our investor event at ASCO 2021. And as you have seen, we had some important data from our oncology pipeline presenters over the weekend, including for our next-generation I-O agent, relatlimab. So there's a lot to cover today in a short time. And I'm joined for today's discussion by Samit Hirawat, our Chief Medical Officer; and by Chris Boerner, our Chief Commercialization Officer. Samit and Chris will go through the slide presentation and then will be available for Q&A at the end. If we can go to our next slide, which contains our forward-looking statement. I'll hand over on Slide 3 to Samit to get the presentation started.

Samit Hirawat
Bristol-Myers Squibb Company - Executive VP & Chief Medical Officer of Global Drug Development

Thank you, Tim, and good afternoon, everyone. I'm happy to have this opportunity to discuss the data presented from our pipeline at this year's ASCO meeting, which is of course a very

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot